Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘biopsy’

November 12, 2020 · Leave a Comment

New research shows markers in donor kidneys that could reduce risks

By Advancing the Science contributor Advancing the Science contributor (@advancingthescience)

By Jay Furst The donation of a kidney to a person in need of a transplant is one of the most profound gifts a person can offer. The process for living kidney donors is safe, and, at Mayo Clinic, which has one of the largest living-donor kidney transplant programs in the U.S., the process is […]

View full entry Comment on this

Tags: Andrew Rule, biopsy, Center for Clinical and Translational Science, clinical research, kidney disease, kidney transplant, living donor, Massini Merzkani, Mayo Clinic Proceedings, Naim Issa


January 30, 2020 · Leave a Comment

A breakthrough in distinguishing benign adrenal tumors from cancerous ones

By Advancing the Science contributor Advancing the Science contributor (@advancingthescience)

By Christoph Bahn Approximately 80 million CT scans are performed in the United States every year. Adrenal tumors are found incidentally in about 5% of these scans. Most of these tumors will turn out to be benign, but a small fraction will be adrenal cortical carcinoma, a type of cancer with high mortality and frequent recurrence; even for […]

View full entry Comment on this

Tags: adrenal tumors, biomarkers, biopsy, cancer, clinical research, CT, endocrine cancer, endocrinology, epidemiology, hormones, Irina Bancos, Mayo Clinic Laboratories


December 30, 2019 · Leave a Comment

Research highlights from Florida – fruitful in 2019

By Advancing the Science contributor Advancing the Science contributor (@advancingthescience)

Florida sunshine doesn’t just contribute to big, juicy oranges. In 2019, Florida was a hotbed of growth for Mayo Clinic Research, with 11.8% more funding leading to new capabilities such as ex vivo perfusion for lungs – leading to more available for transplant, and carbon ion therapy for cancer – currently not available to patients in the U.S. Read on for more on these and other practice transforming activities.

View full entry Comment on this

Tags: artificial intelligence, biopsy, breast cancer, cancer, cancer vaccine, carbon ion therapy, Center for Individualized Medicine, clinical trials, ex vivo lung perfusion, immunology, Keith Knutson, lung cancer


Contact Us · Privacy Policy